No headlines found.
Ridgetech, Inc. Reports Fiscal Year 2026 Financial Results
PRNewswire (Fri, 31-Jul 8:30 AM ET)
PRNewswire (Fri, 24-Jul 8:30 AM ET)
Ridgetech Inc is a wholesale distributor of pharmaceutical and other healthcare products. Currently operate in the offline wholesale distribution of pharmaceutical products mainly to local buyers, while also engaging in online sales through both self-operated and third-party platforms to customers nationwide. The company wholesale business through Jiuxin Medicine, distributing third-party pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicine (TCM), personal and family care products, and medical devices, as well as convenience products, including consumable, seasonal, and promotional items. It has two segments offline wholesale and online platform. The majority revenue generated from offline wholesale.
Ridgetech - trades on the NASDAQ stock market under the symbol RDGT.
As of October 2, 2026, RDGT stock price climbed to $0.87 with 54,784 million shares trading.
RDGT has a beta of 4.84, meaning it tends to be more sensitive to market movements. RDGT has a correlation of 0.02 to the broad based SPY ETF.
RDGT has a market cap of $3.17 million. This is considered a Sub-Micro Cap stock.
RDGT has underperformed the market in the last year with a price return of -99.5% while the SPY ETF gained +16.3%. RDGT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -39.7% and -5.0%, respectively, while the SPY returned +3.5% and +1.4%, respectively.
RDGT support price is $.76 and resistance is $.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RDGT shares will trade within this expected range on the day.
